Markets

Edge Therapeutics (EDGE) Catches Eye: Stock Soars 19.4%

Edge Therapeutics, IncEDGE was a big mover last session, as the company saw its shares rise over 19% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $7.55 to $8.89 in the past one-month time frame.

In the past one month, the company has seen one positive revision and its Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.

Edge Therapeutics has Zacks Rank #2 (Buy), while its Earnings ESP is 0.00%.

Another favorably ranked biomedical stock is HESKA CORP HSKA , sporting a Zacks Rank #1 (Strong Buy).

Is EDGE going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

HESKA CORP (HSKA): Free Stock Analysis Report

EDGE THERAPEUTC (EDGE): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

PDSB HSKA

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More